Histavert 8mg Tablet contains Betahistine, an active pharmaceutical ingredient used primarily in the management of Ménière’s disease and other vestibular disorders characterized by vertigo, tinnitus, and hearing loss. Betahistine acts as a histamine analogue, exerting its therapeutic effects by improving microcirculation in the inner ear and reducing endolymphatic pressure. This action helps alleviate symptoms associated with vestibular dysfunction. The recommended dosage of Histavert 8mg Tablet varies depending on the severity of the condition and patient response, typically administered orally two to three times daily. It is generally well tolerated, with adverse effects being mild and infrequent; these may include gastrointestinal disturbances such as nausea or headache. Caution is advised in patients with a history of peptic ulcers or asthma due to the histaminergic activity of the drug. Histavert should be used under medical supervision, and patients should inform their healthcare provider of any concurrent medications to avoid potential interactions. Regular monitoring and adherence to prescribed dosage are essential to optimize therapeutic outcomes. Histavert 8mg Tablet offers an effective option for symptomatic relief in vestibular disorders, improving patient quality of life through targeted pharmacological intervention.